70 results
8-K
EX-3.1
RYTM
Rhythm Pharmaceuticals Inc.
16 Apr 24
Entry into a Material Definitive Agreement
7:00am
Taxes Upon Issuance of Common Stock
Section 12.
No Preemptive Rights
Section 13.
Tax Treatment
Section 14.
Calculations
Responsibility; Schedule … completed Internal Revenue Service Form W-9.
Section 14. Calculations.
(a) Responsibility; Schedule of Calculations. Except as otherwise provided
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
Stock
Section 12.
No Preemptive Rights
Section 13.
Tax Treatment
Section 14.
Calculations
Responsibility; Schedule of Calculations
Calculations … .
Section 14. Calculations.
(a) Responsibility; Schedule of Calculations. Except as otherwise provided in this Certificate of Designations, the Company
8-K
EX-1.1
RYTM
Rhythm Pharmaceuticals Inc.
29 Feb 24
Entry into a Material Definitive Agreement
4:46pm
responsibility of the Company, and Cowen shall have no obligation in connection with such compliance. The issuance and sale of Common Stock through Cowen
424B5
RYTM
Rhythm Pharmaceuticals Inc.
29 Feb 24
Prospectus supplement for primary offering
4:44pm
no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We will not make an offer … with securities held for the account of customers in bearer form or registered in “street name.” Those payments will be the responsibility
8-K
EX-1.1
vn8ehdl1o2 3ei2zn
15 Sep 22
Other Events
4:02pm
424B5
r39zbfkexs9ftdvitc
15 Sep 22
Prospectus supplement for primary offering
4:00pm
424B5
hhd6fba69r
14 Sep 22
Prospectus supplement for primary offering
4:05pm